In a phase 2 trial, participants lost about a quarter of their body weight over 48 weeks - and the more they took, the more they lost.
Reported weight loss scaled with dose across the trial arms.
Search peptides — top sellers first
Search peptides — top sellers first
Search peptides — top sellers first
GLP receptor-targeting research peptide, supplied for laboratory study only.
$179/ 30mg vial
$89.50 per vial with Buy 1, Get 1 Free
All products currently listed on this site are for research purposes only.
Frequently bought together
Related supplies, one order, one delivery.

Reconstitution Solution · 10ml
Popular

GHK-CU · 50mg

Melanotan 2 · 10mg
Most sellers show one certificate and hope you never ask again. We publish a signed report for every batch we release, tied to the lot number on your vial. Purity is an exact number, not a “passes.” If a batch fails, it never ships.

A triple-incretin research peptide studied for engaging three metabolic receptors at once.
Glucagon-like peptide-1 signalling is studied for glucose-dependent insulin release and appetite regulation.
Glucose-dependent insulinotropic polypeptide is investigated for insulin sensitivity and nutrient handling.
Glucagon-receptor activity is researched for its influence on energy expenditure and hepatic lipid metabolism.
For research use only. Mechanisms described reflect published research literature.
Anyone can show you one good report. Here is every batch of GLP-3-RT we have ever released, newest first, each with its own signed report. Nothing hidden, nothing cherry-picked.
Published findings on this compound, each linked to its source. Animal and lab results are context, not claims about this product.
In a phase 2 trial, participants lost about a quarter of their body weight over 48 weeks - and the more they took, the more they lost.
Reported weight loss scaled with dose across the trial arms.
On the top dose, almost every participant lost at least 10% of their body weight.
Each dot is about 2% of participants; roughly 83% reached at least 15%.
Weight was still dropping at week 48 - the curve had not leveled off when the trial ended.
Relative body weight (baseline = 100); the treated curve had not plateaued by week 48.
Quick answers about GLP-3-RT.
Test any batch at any lab you like. If it doesn't match our report, you get every dollar back. No return shipping, no forms, no arguments.